NIPH Clinical Trials Search

In-house platelet transfusion from a corresponding HLA donor to an anti-HLA-antibody-positive patient

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	Hematologic disorders
Date of first enrollment	2022/12/08
Target sample size	1
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	in-house platelet transfusion

Outcome(s)

Primary Outcome	Titer of donor-specific antibodies
Secondary Outcome	engraftment

Key inclusion & exclusion criteria

Age minimum	18years-old
Age maximum	70years-old
Gender	Male and Female
Include criteria
Exclude criteria	Case that sufficient stem cells cannot be harvested from the donor